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Endocannabinoids serve as retrogrademessengers that are released by postsynaptic cells to regulate neuro-
transmitter release from presynaptic boutons. A new study in this issue of Neuron by Tanimura et al. estab-
lishes that most endocannabinoid signaling in the brain is a consequence of the calcium-dependent or
receptor-driven generation of the retrograde signal 2-arachidonoylglycerol (2-AG) by diacylglycerol lipase
a (DGLa).For nearly 20 years we have known that
depolarizing a postsynaptic cell can
elevate calcium, which can in turn trigger
the release of a retrograde messenger
that acts presynaptically to suppress
neurotransmitter release (Llano et al.,
1991; Pitler and Alger, 1992). This form of
plasticity came tobeknownasdepolariza-
tion-induced suppression of inhibition
(DSI), or DSE for excitatory synapses.
Following a decade of research, it was
discovered that DSI and DSE were medi-
ated by cannabinoid type-1 receptors
(CB1 receptors). The cannabinoid sig-
naling system, so named for its role in
the psychotropic effects of marijuana
(Cannabis sativa), had longbeenof interest
because of its involvement in perception,
motor function, memory, mood, appetite
control, and pain. The realization that
endogenously produced cannabinoids
(endocannabinoids) can act as retrograde
messengers sparked a flurry of studies
that established the importance of retro-
grade endocannabinoid signaling in the
short-term and long-term regulation of
synapses throughout the brain (Heifets
and Castillo, 2009; Kano et al., 2009). It
became clear that there are two major
ways of evoking endocannabinoid
release. For DSI/DSE, endocannabinoid
release is driven by a large increase in
postsynaptic calcium (Figure1A),whereas
for receptor-driven endocannabinoid
release (RER), the activation of Gq/11-
coupled receptors stimulates endocanna-
binoid release (Figure 1B). Pharmacolog-
ical and genetic experiments establishedthat for RER, Gq/11-coupled receptor acti-
vation causesphospholipaseCb (PLCb) to
cleave phosphotidylinositol bisphosphate
(PIP2), yielding diacylglycerol (DAG). DAG
is then cleaved by DAG lipase (DGL) to
generate 2-AG. Importantly, the magni-
tude of RER can be augmented by eleva-
tions of postsynaptic calcium, consistent
with the dependence of PLCb on both
Gq/11-coupled receptors and calcium.
Even as our understanding of RER
advanced considerably, the identity of
the endocannabinoid mediating DSI/
DSE, and how this endocannabinoid is
synthesized, remained controversial (Fig-
ure 1A, top). Evidence suggested that
Gq/11-coupled receptors were not
required for DSI/DSE, but the role of
DGL and the involvement of 2-AG were
less clear. Sometimes, inhibiting DGL pre-
vented RER without affecting DSI/DSE,
whereas in other cases inhibiting DGL
suppressed DSI/DSE (Kano et al., 2009).
The variability in the results could have re-
flected either the differential ability of the
mechanisms underlying DSI/DSE and
RER to evoke endocannabinoid release
when some DGL activity remained, or
complications associated with the phar-
macology. Thus, it was possible that en-
docannabinoids other than 2-AG, such
as anandamide, might contribute to DSI/
DSE. Alternatively, 2-AG could have
been involved, but via a pathway involving
phospholipase A1 (PLA1) rather than DGL.
Moreover, a molecular approach was
needed to determine the roles of DGL iso-
forms in DSI/DSE and RER.Neuron 65,As detailed in this issue ofNeuron, Tani-
mura et al. (2010) therefore generated two
strains of mice deficient in the a and b iso-
forms of DGL. They found that all aspects
of 2-AG signaling and retrograde sup-
pression of synapses were normal in
DGLb knockout animals (b-KO). In
contrast, in DGLa knockout animals (a-
KO), 2-AG content was drastically
reduced, and both RER and DSI/DSE
wereeliminatedat inhibitory andexcitatory
synapses in the cerebellum, the hippo-
campus, and the striatum. Although the
emphasis was on short-term suppression
of synaptic strength, they also showed
that endocannabinoid-dependent chemi-
cal long-term depression at hippocampal
inhibitory synapses (iLTD) was greatly
diminishedwithin the a-KO. The investiga-
tors also included a number of important
control experiments showing that in a-KO
animals, the distributions of CB1 recep-
tors, PLCb, and metabotropic glutamate
receptors (mGluRs) were normal; mGluRs
functionednormally; anddendritic calcium
signaling was similar to that of wild-type
animals. Oddly, they found that the basal
levels of anandamide, an endocannabi-
noid not synthesized by DGL, were also
somewhat reduced in a-KO animals.
However, this reduction in anandamide
levels (30%–50%) was much less than
the reduction in 2-AG levels, and did not
seem to be sufficient to account for the
elimination of RER and DSI/DSE seen in
a-KO animals. Thus, the authors establish
that DGLa is the primary enzyme utilized
to synthesize the endocannabinoidFebruary 11, 2010 ª2010 Elsevier Inc. 291
Figure 1. Diacylglycerol Lipase a (DGLa) Is
Necessary for Depolarization-Induced and
Receptor-Driven Endocannabinoid Release
Schematics are shown for two types of retrograde
signaling: depolarization-induced suppression of
inhibition and excitation (DSI/DSE; A) and receptor-
driven endocannabinoid release (RER; B). Advances
made in ourunderstanding of retrograde signalingby
Tanimura et al. are indicated in red. (A) (Top) For DSI/
DSE, calcium influx resulting from postsynaptic
depolarization stimulates the release of a retrograde
messenger that acts at presynaptic cannabinoid
type-1 receptors (CB1Rs) to suppress transmitter
release. There hadbeencontroversy over the identity
of the retrograde messenger for DSI/DSE and the
synthetic pathway involved in the synthesis of this
messenger. (A) (Bottom) It is now known that DGLa
is necessary for DSI/DSE. This indicates that 2-AG
is the endocannabinoid mediator of this signaling. It
is unknown how postsynaptic calcium accumulation
results in thenecessary diacylglycerol (DAG) produc-
tion required forDGLa-dependent formationof 2-AG.
Twopossibilities includephospholipaseC (PLC) acti-
vation without Gq/11-coupled receptor activity or
conversion of phosphatidic acid (PA) to DAG by PA
phosphohydralase (PAP). (B) Activation of Gq/11-
coupled receptors stimulates the release of 2-AG,
which acts at presynaptic CB1Rs to suppress trans-
mitter release.Thisprocess isenhancedby increases
in postsynaptic calcium levels. Activation of Gq/11-
coupled receptors stimulates PLCb, leading to
formation of DAG. DAG is then converted to the
endocannabinoid2-AGbyDGL. Itwasnotpreviously
knownwhich isoform of DGL (a or b) was involved in
RER. It is now known that RER is mediated by 2-AG
that is synthesized by DGLa.
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signaling examined in this study, indicating
that 2-AG is the principal molecule
involved in this signaling (Figure 1A,
bottom, and Figure 1B).
This study also raises questions
regarding how a calcium increase triggers
the synthesis of 2-AG during DSI/DSE.
Genetic deletion of PLCb isoforms
prevents RER but leaves DSI/DSE unal-
tered at hippocampal and cerebellar syn-
apses, indicating that PLCb produces
DAG in RER (Hashimotodani et al., 2005;
Maejima et al., 2005). The identity of the
molecule that drives DAG production
during DSI/DSE is still unknown. Other
isoforms of PLC that are calcium-depen-
dent but Gq/11-independent are potential
candidates, although a number of studies
have found a lack of effect of non-iso-
form-specific PLC inhibitors on DSI
(Chevaleyre and Castillo, 2003; Edwards
et al., 2006; Szabo et al., 2006). Alterna-
tively, a second pathway may exist for
production of DAG involving the enzyme
phosphatidic acid phosphohydralase
(PAP) acting on phosphatidic acid (PA)
(Figure 1A, bottom). The development of
more selective pharmacological tools, as
well as the use of new genetic manipula-
tions, will be required to fully elucidate
the pathway for production of 2-AG
during DSI/DSE.
While it seems reasonable to conclude
that the bulk of retrograde endocannabi-
noid signaling throughout the brain,
whether driven by calcium alone or by
calcium and Gq/11-coupled receptors, is
a consequence of 2-AG produced by
DGLa, future studies will establish if there
are alternative pathways that can lead to
the synthesis of 2-AGor other endocanna-
binoids. It will be of particular interest
to examine some forms of endocannabi-
noid-dependent LTD involving condi-
tioning paradigms that are different from
those used to induce RER or DSI/DSE
(Heifets and Castillo, 2009). For instance,
prolonged low-frequency stimulation of
afferents in the lateral amygdala results
in LTD at inhibitory synapses. This LTD
is thought to be dependent on release
of anandamide following activation of
protein kinase A (Azad et al., 2004). Exam-
ining this formof plasticity ina-KOanimals
would be highly informative.
The a-KO animals developed by
Tanimura et al. (2010) promise to be usefulevier Inc.tools in the study of the endocannabinoid-
signaling system and behavior. Thus far,
most insights into the endocannabinoid
signaling system have been provided by
global and selective knockouts of CB1
receptors (CB1R-KO animals). It is pre-
dicted that behavioral deficits in CB1R-KO
animals and a-KO animals should be
identical for behaviors that are mediated
by 2-AG that is synthesized by DGLa.
In contrast, behavioral deficits will be
different for CB1R-KO animals and a-KO
animals for behaviors that are mediated
by endocannabinoids synthesized by a
pathway that does not involve DGLa, and
for behaviors relying on 2-AG synthesized
byDGLa that act on targets other thanCB1
receptors.
Thus, by creating DGLa and DGLb
knockout animals, and establishing the
central role of DGLa in the synthesis of
2-AG in retrograde signaling, Tanimura
et al. have made a major step forward in
our understanding of endocannabinoid
signaling, and have opened up promising
new areas of research.
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